Globe Life Inc.
GL · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.14 | 7.83 | 32.83 | -0.77 |
| FCF Yield | 1.75% | 2.84% | 3.82% | 3.44% |
| EV / EBITDA | 27.95 | 37.13 | 38.64 | 34.29 |
| Quality | ||||
| ROIC | 98.35% | 54.41% | 53.38% | 61.43% |
| Gross Margin | 41.30% | 30.82% | 31.06% | 31.88% |
| Cash Conversion Ratio | – | – | 1.70 | 1.32 |
| Growth | ||||
| Revenue 3-Year CAGR | 5.04% | 5.29% | 5.29% | 3.48% |
| Free Cash Flow Growth | -29.26% | -29.79% | 30.51% | 3.42% |
| Safety | ||||
| Net Debt / EBITDA | 4.70 | 7.33 | 7.32 | 7.39 |
| Interest Coverage | 13.20 | 8.98 | 9.03 | 8.75 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -10.32 | -4.77 | -6.17 | -5.54 |